Pharmaceuticals and Biotechnology RD and Forecast Market

List of Tables
Table 1. Pharmaceuticals and Biotechnology R&D Market Opportunities & Trends in Global Market
Table 2. Pharmaceuticals and Biotechnology R&D Market Drivers in Global Market
Table 3. Pharmaceuticals and Biotechnology R&D Market Restraints in Global Market
Table 4. Key Players of Pharmaceuticals and Biotechnology R&D in Global Market
Table 5. Top Pharmaceuticals and Biotechnology R&D Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pharmaceuticals and Biotechnology R&D Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pharmaceuticals and Biotechnology R&D Product Type
Table 9. List of Global Tier 1 Pharmaceuticals and Biotechnology R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pharmaceuticals and Biotechnology R&D Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2023-2028
Table 30. ROCHE Corporate Summary
Table 31. ROCHE Pharmaceuticals and Biotechnology R&D Product Offerings
Table 32. ROCHE Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 33. JOHNSON & JOHNSON Corporate Summary
Table 34. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product Offerings
Table 35. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 36. MERCK Corporate Summary
Table 37. MERCK Pharmaceuticals and Biotechnology R&D Product Offerings
Table 38. MERCK Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 39. NOVARTIS Corporate Summary
Table 40. NOVARTIS Pharmaceuticals and Biotechnology R&D Product Offerings
Table 41. NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 42. PFIZER Corporate Summary
Table 43. PFIZER Pharmaceuticals and Biotechnology R&D Product Offerings
Table 44. PFIZER Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 45. SANOFI Corporate Summary
Table 46. SANOFI Pharmaceuticals and Biotechnology R&D Product Offerings
Table 47. SANOFI Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 48. BAYER Corporate Summary
Table 49. BAYER Pharmaceuticals and Biotechnology R&D Product Offerings
Table 50. BAYER Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 51. BRISTOL-MYERS SQUIBB Corporate Summary
Table 52. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product Offerings
Table 53. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 54. ASTRAZENECA Corporate Summary
Table 55. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product Offerings
Table 56. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 57. GLAXOSMITHKLINE Corporate Summary
Table 58. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product Offerings
Table 59. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 60. ABBVIE Corporate Summary
Table 61. ABBVIE Pharmaceuticals and Biotechnology R&D Product Offerings
Table 62. ABBVIE Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 63. ELI LILLY Corporate Summary
Table 64. ELI LILLY Pharmaceuticals and Biotechnology R&D Product Offerings
Table 65. ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 66. BOEHRINGER SOHN Corporate Summary
Table 67. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product Offerings
Table 68. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 69. AMGEN Corporate Summary
Table 70. AMGEN Pharmaceuticals and Biotechnology R&D Product Offerings
Table 71. AMGEN Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 72. GILEAD SCIENCES Corporate Summary
Table 73. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product Offerings
Table 74. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 75. TAKEDA PHARMACEUTICAL Corporate Summary
Table 76. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product Offerings
Table 77. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 78. NOVO NORDISK Corporate Summary
Table 79. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product Offerings
Table 80. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 81. BIOGEN Corporate Summary
Table 82. BIOGEN Pharmaceuticals and Biotechnology R&D Product Offerings
Table 83. BIOGEN Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 84. ABBOTT Corporate Summary
Table 85. ABBOTT Pharmaceuticals and Biotechnology R&D Product Offerings
Table 86. ABBOTT Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 87. ASTELLAS PHARMA Corporate Summary
Table 88. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product Offerings
Table 89. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
Table 90. TEVA PHARMACEUTICAL INDUSTRIES Corporate Summary
Table 91. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product Offerings
Table 92. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pharmaceuticals and Biotechnology R&D Segment by Type in 2021
Figure 2. Pharmaceuticals and Biotechnology R&D Segment by Application in 2021
Figure 3. Global Pharmaceuticals and Biotechnology R&D Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharmaceuticals and Biotechnology R&D Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharmaceuticals and Biotechnology R&D Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceuticals and Biotechnology R&D Revenue in 2021
Figure 8. By Type - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 12. US Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 16. Germany Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 17. France Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 24. China Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 28. India Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 30. Brazil Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue Market Share, 2017-2028
Figure 33. Turkey Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pharmaceuticals and Biotechnology R&D Revenue, (US$, Mn), 2017-2028
Figure 37. ROCHE Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. MERCK Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PFIZER Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. SANOFI Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BAYER Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. ABBVIE Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. AMGEN Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. BIOGEN Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. ABBOTT Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)